TP53 and neoplasm: From these experiments, it is evident that the adenovirus-mediated PTTG1-siRNA appears to selectively target tumor cells expressing high levels of PTTG1 with functional p53, which may serve as a valuable gene therapy approach for treating human cancers including ovarian cancer.